• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number ETCF2525C49E
Device Problem Inaccurate Delivery (2339)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 01/04/2014
Event Type  Injury  
Event Description
An endurant stent graft was implanted in the patient for the endovascular treatment of an abdominal aortic aneurysm.The aneurysm at time of implant was reported to be 77.8 mm in size.It was reported that approximately five years post index procedure a follow-up ct scan indicated that the patient¿s aneurysm had continued to enlarge.The physician noted that the patient has a type ii endoleak ima embolization with sac coils.There was no evident endoleak or migration seen; however, the physician also noted the possibility of a potential type iii (fabric) endoleak.The physician decided to add an endurant cuff 25x25 on the proximal side and realign the limbs with a 16x93 on the right side and 16x124 on the left.The physician deployed the cuff and attempted to shorten it slightly with proximal pressure on the delivery handle; however, the cuff partially covered the left renal.The physician is not planning additional treatment since the renal artery is small in diameter and poorly functioning prior to the intervention.The type iii endoleak resolved after the intervention.The type ii endoleak was left unresolved.No additional clinical sequelae were reported and the patient will be monitored by the physician.
 
Manufacturer Narrative
(b)(4): evaluation, results: inherent risk of procedure (occlusion).Patient¿s condition affected effectiveness of device (anatomy related; type ii endoleak).Incorrect technique/procedure (user related).Conclusions: inherent risk of a procedure (occlusion).Device failure/lack of effectiveness related to patient condition (anatomy related; type ii endoleak).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC CARDIOVASCULAR
3576 unocal place
santa rosa CA 95403
Manufacturer Contact
ludmila voulfson
3576 unocal place
santa rosa, CA 95403
7075661229
MDR Report Key3667882
MDR Text Key16799109
Report Number2953200-2014-00393
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 02/10/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/07/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/04/2015
Device Catalogue NumberETCF2525C49E
Device Lot NumberV04110697
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/10/2014
Date Device Manufactured09/04/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00092 YR
Patient Weight77
-
-